Lista de obras -

187 Reduction in Asthma Deteriorations in Subjects with Persistent Asthma not Well Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids: A Pooled Analysis From Three Clinical Trials Using Combined Mometasone Furoate/Formoterol

188 Efficacy Comparison of Mometasone Furoate/Formoterol Versus Fluticasone Propionate/Salmeterol Combination Therapies in Subjects With Persistent Asthma: Noninferiority and Onset-of-Action Findings.

artículo científico publicado en 2012

190 Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal Awakenings in Subjects With Persistent Asthma.

artículo científico publicado en 2012

191 Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined Mometasone Furoate and Formoterol.

artículo científico publicado en 2012

192 Efficacy and Safety of Combined Mometasone Furoate/Formoterol 100/10ìG Twice Daily in Subjects with Asthma Inadequately Controlled on Low-Dose Inhaled Corticosteroids.

artículo científico publicado en 2012

4 The Risk of Severe Treatment Related Adverse Events is Significantly Lower in Children Compared to Adults When Treated With Standardized Timothy Grass Allergy Immunotherapy Tablets: Post Hoc Analysis of 7 Clinical Trials

A population-based clinical study of allergic and non-allergic asthma

artículo científico publicado en 2009

A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice

artículo científico publicado en 2017

Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles

artículo científico publicado en 2017

Allergy to oak pollen in North America

artículo científico publicado en 2021

Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.

artículo científico publicado en 2014

Association of airway hyperresponsiveness with reduced quality of life in patients with moderate to severe asthma

scientific article published on 01 January 2007

Asthma control using a combination of mometasone furoate/formoterol: grouped analysis of three clinical trials

artículo científico publicado en 2011

Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma

artículo científico publicado en 2013

Changes in skin test reactivity among adults with atopic disease: a 3-year prospective study

artículo científico publicado en 2008

Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report

scientific article published on 15 May 2020

Comparison of the novel CompEx asthma exacerbation endpoint to the ATS/ERS adapted moderate/severe asthma exacerbation definition used in the MITRA trial

artículo científico publicado en 2019

Coseasonal Initiation of Allergen Immunotherapy: A Systematic Review

artículo científico publicado en 2016

Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma

Effect of Grass Sublingual Tablet Immunotherapy is Similar in Children and Adults: A Bayesian Approach To Design Pediatric Sublingual Immunotherapy Trials

artículo científico publicado en 2017

Effect of allergen-specific immunotherapy on recombinant human interleukin 3-mediated amplification of allergen-induced basophil histamine release

scientific article published on 01 November 2005

Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma

artículo científico publicado en 2011

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma ⬇️

artículo científico publicado el 7 de diciembre de 2011

Efficacy and safety of MK-7243: a grass allergy sublingual immunotherapy tablet evaluated in Canadian adults and children.

artículo científico publicado en 2014

Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial

artículo científico publicado en 2013

Efficacy and safety of medium and high doses of mometasone furoate/formoterol (MF/F) combination treatment in subjects with severe persistent asthma.

artículo científico publicado en 2010

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

artículo científico publicado en 2014

Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis

artículo científico publicado en 2014

Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults

artículo científico publicado en 2011

Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents ⬇️

artículo científico publicado el 1 de enero de 2011

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC).

artículo científico publicado en 2011

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial

artículo científico

Efficacy of short-ragweed sublingual immunotherapy tablet MK-3641 in monosensitized and polysensitized subjects

artículo científico publicado en 2014

Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets

artículo científico publicado en 2016

Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet

artículo científico publicado en 2018

In vitro diagnostic evaluation of patients with inhalant allergies: summary of probability outcomes comparing results of CLA- and CAP-specific immunoglobulin E test systems

artículo científico publicado en 2003

Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects

artículo científico publicado en 2005

Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial

artículo científico

Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma

artículo científico publicado en 2010

Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: dependency on levels of pollen exposure.

artículo científico publicado en 2014

Major allergen content consistency of SQ house dust mite sublingual immunotherapy tablets and relevance across geographic regions

artículo científico publicado en 2016

Non-inferiority efficacy comparison of mometasone furoate/formoterol versus fluticasone propionate/salmeterol combination therapies in subjects with persistent asthma.

artículo científico publicado en 2010

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

artículo científico publicado en 2015

Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents

artículo científico publicado en 2017

Quality of care in patients with asthma and rhinitis treated by respiratory specialists and primary care physicians: a 3-year randomized and prospective follow-up study

scientific article published on 01 October 2006

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults

artículo científico publicado en 2013

Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults

artículo científico

SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.

artículo científico publicado en 2016

SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration.

artículo científico publicado en 2018

Safety and tolerability of a short ragweed sublingual immunotherapy tablet

artículo científico

Safety of Timothy Grass Sublingual Immunotherapy Tablet in Children: Pooled Analyses of Clinical Trials

scientific article published on 15 January 2020

Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites

artículo científico publicado en 2015

Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis

artículo científico publicado en 2012

Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.

artículo científico publicado en 2016

Short ragweeds is highly cross-reactive with other ragweeds

artículo científico publicado en 2015

Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma

artículo científico publicado en 2017

Sublingual immunotherapy: a comprehensive review.

artículo científico publicado en 2006

The effect of generalist and specialist care on quality of life in asthma patients with and without allergic rhinitis

artículo científico publicado en 2010

The effect of the ragweed sublingual immunotherapy tablet MK-3641 on rescue medication use.

artículo científico publicado en 2014

The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms

artículo científico publicado en 2017

The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children

artículo científico publicado en 2014

The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis

scholarly article by Jennifer Maloney et al published 2014 in Allergy, Asthma & Clinical Immunology

The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases

article

Timothy specific IgE levels are associated with efficacy and safety of timothy grass sublingual immunotherapy tablet

artículo científico

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses

artículo científico publicado en 2016

Treatment of severe asthma with anti-immunoglobulin E (Omalizumab). A new possibility in pulmonary medicine

artículo científico publicado en 2007

Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids

artículo científico publicado en 2010

Unawareness and undertreatment of asthma and allergic rhinitis in a general population

artículo científico publicado en 2005

Lista de obras de

187 Reduction in Asthma Deteriorations in Subjects with Persistent Asthma not Well Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids: A Pooled Analysis From Three Clinical Trials Using Combined Mometasone Furoate/Formoterol

188 Efficacy Comparison of Mometasone Furoate/Formoterol Versus Fluticasone Propionate/Salmeterol Combination Therapies in Subjects With Persistent Asthma: Noninferiority and Onset-of-Action Findings.

190 Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal Awakenings in Subjects With Persistent Asthma.

191 Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined Mometasone Furoate and Formoterol.

192 Efficacy and Safety of Combined Mometasone Furoate/Formoterol 100/10ìG Twice Daily in Subjects with Asthma Inadequately Controlled on Low-Dose Inhaled Corticosteroids.

4 The Risk of Severe Treatment Related Adverse Events is Significantly Lower in Children Compared to Adults When Treated With Standardized Timothy Grass Allergy Immunotherapy Tablets: Post Hoc Analysis of 7 Clinical Trials

A population-based clinical study of allergic and non-allergic asthma

A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice

Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles

Allergy to oak pollen in North America

Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.

Association of airway hyperresponsiveness with reduced quality of life in patients with moderate to severe asthma

Asthma control using a combination of mometasone furoate/formoterol: grouped analysis of three clinical trials

Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma

Changes in skin test reactivity among adults with atopic disease: a 3-year prospective study

Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report

Comparison of the novel CompEx asthma exacerbation endpoint to the ATS/ERS adapted moderate/severe asthma exacerbation definition used in the MITRA trial

Coseasonal Initiation of Allergen Immunotherapy: A Systematic Review

Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma

Effect of Grass Sublingual Tablet Immunotherapy is Similar in Children and Adults: A Bayesian Approach To Design Pediatric Sublingual Immunotherapy Trials

Effect of allergen-specific immunotherapy on recombinant human interleukin 3-mediated amplification of allergen-induced basophil histamine release

Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma ⬇️

Efficacy and safety of MK-7243: a grass allergy sublingual immunotherapy tablet evaluated in Canadian adults and children.

Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial

Efficacy and safety of medium and high doses of mometasone furoate/formoterol (MF/F) combination treatment in subjects with severe persistent asthma.

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis

Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults

Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents ⬇️

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC).

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial

Efficacy of short-ragweed sublingual immunotherapy tablet MK-3641 in monosensitized and polysensitized subjects

Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets

Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet

In vitro diagnostic evaluation of patients with inhalant allergies: summary of probability outcomes comparing results of CLA- and CAP-specific immunoglobulin E test systems

Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects

Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial

Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma

Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: dependency on levels of pollen exposure.

Major allergen content consistency of SQ house dust mite sublingual immunotherapy tablets and relevance across geographic regions

Non-inferiority efficacy comparison of mometasone furoate/formoterol versus fluticasone propionate/salmeterol combination therapies in subjects with persistent asthma.

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents

Quality of care in patients with asthma and rhinitis treated by respiratory specialists and primary care physicians: a 3-year randomized and prospective follow-up study

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults

Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults

SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.

SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration.

Safety and tolerability of a short ragweed sublingual immunotherapy tablet

Safety of Timothy Grass Sublingual Immunotherapy Tablet in Children: Pooled Analyses of Clinical Trials

Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites

Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis

Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.

Short ragweeds is highly cross-reactive with other ragweeds

Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma

Sublingual immunotherapy: a comprehensive review.

The effect of generalist and specialist care on quality of life in asthma patients with and without allergic rhinitis

The effect of the ragweed sublingual immunotherapy tablet MK-3641 on rescue medication use.

The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms

The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children

The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis

The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases

Timothy specific IgE levels are associated with efficacy and safety of timothy grass sublingual immunotherapy tablet

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses

Treatment of severe asthma with anti-immunoglobulin E (Omalizumab). A new possibility in pulmonary medicine

Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids

Unawareness and undertreatment of asthma and allergic rhinitis in a general population